IPG Photonics Posts Third Straight Quarter of Double‑Digit Growth

Rising demand for battery‑welding and AI‑related semiconductor work, paired with tariff pressure on costs, creates a mixed margin outlook.

Overview

IPG reported second‑quarter revenue of $279 million, an 11% year‑over‑year increase that marks the company’s third consecutive quarter of double‑digit sales growth.
Profitability beat expectations with a 40.7% adjusted gross margin and $0.58 adjusted EPS, and the company finished the quarter with about $904 million in cash and no debt.
Industrial solutions led the quarter, with battery‑welding work for electric‑vehicle and stationary‑storage batteries plus marking, cleaning and additive manufacturing driving the gains.
Order intake improved and book‑to‑bill stayed above one, supporting near‑term revenue visibility, and management gave third‑quarter guidance of $265 million to $295 million in revenue and $0.30 to $0.60 adjusted EPS that factors in a roughly 150‑basis‑point tariff drag on gross margin.
IPG agreed to buy Lumibird Medical to expand its medical addressable market by about $1 billion, a move that together with the company’s strong cash position gives management flexibility to diversify beyond industrial and semiconductor exposure.